94 results
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
, insurance companies, and certain other financial institutions;
U.S. expatriates and certain former citizens or long-term residents of the United States … or loss realized on the sale or other taxable disposition of ADSs will be capital gain or loss, and will be a long-term capital gain or loss if the U.S
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
and treated with obe-cel continue to be monitored in the Phase 1 ALLCAR19 trial. A pooled analysis of long-term follow-up data from ALLCAR19 and FELIX Phase 1b … . These therapies also require long-term administration and can have serious side effects.
Recently a small academic clinical trial conducted
8-K/A
EX-99.1
AUTL
Autolus Therapeutics plc
15 Mar 24
Results of Operations and Financial Condition
4:21pm
is very encouraging when you think about the potential for long-term outcomes in these patients. Now if we go to slide number 14, we also see an impact … proposition because it suggests that indeed a significant proportion of the patients manage to get into a long-term remission. In these patients, you can see
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
14 Mar 24
Results of Operations and Financial Condition
12:32pm
ASH 2023 ALLCAR19 Phase 1b /FELIX Ph 1b
Long-term follow up in R/R B-ALL demonstrates favorable EFS and OS Developing Next Generation Programmed T
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
14 Mar 24
Results of Operations and Financial Condition
12:32pm
follow up of3 years. Further long-term data from the FELIX study is anticipated at medical conferences in 2024. Obe-cel in B-cell mediated autoimmune
8-K
EX-99.1
3n7yvrzwypp094m6w
13 Feb 24
Regulation FD Disclosure
4:06pm
424B5
we0y1rnqv4 5hyz
9 Feb 24
Prospectus supplement for primary offering
5:15pm
8-K
EX-99.1
xtzoxqxc7yz
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
S-3ASR
e8ju2zc5 x62eld9i
7 Feb 24
Automatic shelf registration
10:00pm
8-K
eyrftou9il0 jgy5y2
11 Dec 23
Regulation FD Disclosure
8:31am
8-K
EX-99.2
rgtzcorjg82py 3pin
11 Dec 23
Regulation FD Disclosure
8:31am
8-K
EX-99.1
qtiywrhxf9o99
11 Dec 23
Regulation FD Disclosure
8:31am
10-Q
EX-10.2
ntniv
9 Nov 23
Quarterly report
4:18pm
10-Q
r7x2yr y8ny27ypr
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.3
own j4rj8jwlxdsecco
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.2
3kzl zg4ajrpj0rm
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.1
x1om2q icp
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.1
co6iwy xvremb8
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
r59ny1crvei6
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.3
891vmw3
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm